123 related articles for article (PubMed ID: 11886762)
1. The meaning of mammographic breast density in users of postmenopausal hormone therapy.
Speroff L
Maturitas; 2002 Mar; 41(3):171-5. PubMed ID: 11886762
[No Abstract] [Full Text] [Related]
2. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
3. Breast density changes associated with hormone replacement therapy in postmenopausal women. Effects on the specificity and sensitivity of mammographic screening.
Patella A; Marziani R; Schippa A; Benedetti S; Mossa S; Mossa B
Eur J Gynaecol Oncol; 2005; 26(5):485-90. PubMed ID: 16285562
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
5. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity.
Harvey JA; Pinkerton JV; Herman CR
J Natl Cancer Inst; 1997 Nov; 89(21):1623-5. PubMed ID: 9362162
[No Abstract] [Full Text] [Related]
6. Breast density as a clinical entity: is it a marker for breast cancer?
Nachtigall LE
Menopause; 2007; 14(3 Pt 1):345-6. PubMed ID: 17413840
[No Abstract] [Full Text] [Related]
7. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
Laya MB; Larson EB; Taplin SH; White E
J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640
[TBL] [Abstract][Full Text] [Related]
8. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Byers T; Trujillo S; Hines L
J Natl Cancer Inst; 2008 Apr; 100(8):596. PubMed ID: 18398102
[No Abstract] [Full Text] [Related]
9. Mammographic density, response to hormones, and breast cancer risk.
Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
[TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Mammogram recall rates after stopping hormone therapy.
Ann Intern Med; 2009 Jun; 150(11):I28. PubMed ID: 19487707
[No Abstract] [Full Text] [Related]
11. Postmenopausal hormone therapy and change in mammographic density.
Greendale GA; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Ursin G
J Natl Cancer Inst; 2003 Jan; 95(1):30-7. PubMed ID: 12509398
[TBL] [Abstract][Full Text] [Related]
12. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L
J Natl Cancer Inst; 2008 Apr; 100(8):597-8; author reply 599. PubMed ID: 18398101
[No Abstract] [Full Text] [Related]
13. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
[TBL] [Abstract][Full Text] [Related]
14. Short-term hormone therapy suspension and mammography recall: a randomized trial.
Buist DS; Anderson ML; Reed SD; Aiello Bowles EJ; Fitzgibbons ED; Gandara JC; Seger D; Newton KM
Ann Intern Med; 2009 Jun; 150(11):752-65. PubMed ID: 19487710
[TBL] [Abstract][Full Text] [Related]
15. Mammographic changes in postmenopausal women on hormonal replacement therapy.
Marugg RC; van der Mooren MJ; Hendriks JH; Rolland R; Ruijs SH
Eur Radiol; 1997; 7(5):749-55. PubMed ID: 9166577
[TBL] [Abstract][Full Text] [Related]
16. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Chu DZ
J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
[No Abstract] [Full Text] [Related]
17. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?
Sterns EE; Zee B
Breast Cancer Res Treat; 2000 Jan; 59(2):125-32. PubMed ID: 10817347
[TBL] [Abstract][Full Text] [Related]
18. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal hormone therapy and breast cancer: a clinician's message for patients.
Speroff L
Endocrine; 2004 Aug; 24(3):211-6. PubMed ID: 15542887
[TBL] [Abstract][Full Text] [Related]
20. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT
Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
